18 June 2024 : Original article
Implementation and Evaluation of Discharge Planning for Patients Undergoing Umbilical Cord Blood Transplantation
Lu Huang
DOI: 10.12659/AOT.943770
Ann Transplant 2024; 29:e943770
Table 4 Effects of discharge planning on clinical outcomes.
Outcomes | CG (n=32) | IG (n=34) | p value | |
---|---|---|---|---|
Time to neutrophil engraftment (days) | Median (range) | 15 (10–23) | 16 (12–32) | 0.085 |
Time to platelet engraftment (days) | 34 (20–109) | 34 (23–98) | 0.586 | |
Infections | Number | |||
bacterial infections | 18 | 14 | 0.221 | |
fungal infections | 7 | 9 | 0.663 | |
viral infections | 20 | 18 | 0.432 | |
aGVHD | Number | 0.527 | ||
Non-aGVHD | 23 | 24 | ||
Grade 1–2 | 4 | 7 | ||
Grade 3–4 | 5 | 3 | ||
Hemorrhagic cystitis | Number | 10 | 8 | 0.482 |
Loss of weight >10% | Number | 14 | 18 | 0.455 |
Hospital LOS | Median (range) | 53.5 (35, 79) | 49 (33, 72) | 0.245 |
aGVHD – acute graft-versus-host-disease; LOS – length of stay. |